Most people think venture capitalists provide the money to Silicon Valley high tech companies. However, Scott M. Rocklage, Ph.D and 5AM Ventures seek out the early-stage life science companies that will deliver superior return on investment. 5AM Ventures back the next generation of companies tackling important healthcare problems. Rocklage is 5AM Ventures’s Managing Partner. Read more: Scott Rocklage | LinkedIn
He graduated from the University of California, Berkeley with a degree in Chemistry. He earned his Ph.D in Chemistry from MIT. There he worked in the laboratory of Richard R. Shrock, the 2005 Nobel Prize for Chemistry winner.
Rocklage owns or co-owns over 30 patents. He has over 100 peer-reviewed scientific publications. He lives in Boston Massachusetts. He has held many research and development jobs with Catalytica and Salutar.
He has served as CEO and Chairman of biotechnology firms himself. These are Cubist Pharmaceuticals, Nycomed Salutar and Catalytica.
He was the Executive Chairman of Miikana, which was acquired by EntreMed, and Ilypsa, which was bought up by Amgen. Teleflex bought up his company Semprus.
He joined 5AM Ventures in 2003 as a Venture Partner. He became the Manager Partner in 2004. He has over 30 years of experience in the biotechnology field. He has helped three new drugs gain FDA approval: Omniscan, Teslascan and Cubicin.
He is now the Board Chairman at Cidarus, Rennovia and Kinestral. He’s on the boards of Pulmatrix and Epirus.
To accomplish all that, Rocklage must be well organized. When interviewed by Idea Mensch, he said that time management made him more productive as an entrepreneur.
According to Patty Rocklage, most of his failures have come from hiring the wrong people. He advises entrepreneurs to move on quickly when they’ve discovered that. He says that if he had to start over again, he would put more emphasis on the people he hired. Team building is important from the start of a new company.
He advises new entrepreneurs to not fear measured risk-taking. Through entrepreneurship, you control your future more than if you work for a Fortune 500 company.
Learn more about Scott Rocklage: